000			02018 a2200589 4500
005			20250515185754.0
264		0	_c20091113
008			200911s 0 0 eng d
022			_a1526-632X
024	7		_a10.1212/WNL.0b013e3181b87942 _2doi
040			_aNLM _beng _cNLM
100	1		_aConnor, K M
245	0	0	_aRandomized, controlled trial of telcagepant for the acute treatment of migraine. _h[electronic resource]
260			_bNeurology _cSep 2009
300			_a970-7 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAzepines _xadministration & dosage
650	0	4	_aCalcitonin Gene-Related Peptide _xantagonists & inhibitors
650	0	4	_aCalcitonin Gene-Related Peptide Receptor Antagonists
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aEndpoint Determination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHyperacusis _xdrug therapy
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMigraine Disorders _xdrug therapy
650	0	4	_aNausea _xetiology
650	0	4	_aOutcome Assessment, Health Care
650	0	4	_aPain Measurement
650	0	4	_aPhotophobia _xdrug therapy
650	0	4	_aPlacebos
650	0	4	_aQuality of Life
650	0	4	_aReceptors, Calcitonin Gene-Related Peptide _xmetabolism
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTreatment Outcome
700	1		_aShapiro, R E
700	1		_aDiener, H-C
700	1		_aLucas, S
700	1		_aKost, J
700	1		_aFan, X
700	1		_aFei, K
700	1		_aAssaid, C
700	1		_aLines, C
700	1		_aHo, Tony W
773	0		_tNeurology _gvol. 73 _gno. 12 _gp. 970-7
856	4	0	_uhttps://doi.org/10.1212/WNL.0b013e3181b87942 _zAvailable from publisher's website
999			_c19167577 _d19167577